News about Global Pharma

H.E.L Group Signs Research Deal with ICT Mumbai to Boost Chemical Synthesis Industry

As part of the agreement, H.E.L will provide ICT Mumbai with a Simular Process Development Reaction Calorimeter, designed for applications including adiabatic calorimetry, autocatalysis, and batch and semi-batch reactors.

Global Pharma | 15/03/2025 | By Aishwarya |  464

Zealand Pharma and Roche to Develop and Commercialize Petrelintide

The two companies will co-develop and co-commercialize petrelintide and combination products with petrelintide, including a fixed-dose combination product of petrelintide and CT-388, Roche’s lead incretin asset and potential best-in-class GLP-1/GIP receptor dual agonist.

Global Pharma | 15/03/2025 | By Aishwarya |  414

GT Metabolic Gets FDA Approval for 50mm MagDI System to Expand Surgery Options

GT Metabolic™ Solutions, Inc., announce that the US Food and Drug Administration (FDA) has cleared a larger, 50mm MagDI™ System magnet to complement the system's existing 40mm magnet.

Global Pharma | 13/03/2025 | By Manvi |  699

Caliber Launches 4 AI-driven Solutions to Revolutionise Pharma Manufacturing

Caliber has launched four new digital solutions—CalGenie, CaliberMetrix, CaliberPulse, and CalWare360—reinforcing its leadership in Pharma 4.0 and advancing digital transformation.

Global Pharma | 13/03/2025 | By Manvi |  333

Zynext Ventures Backs Illexcor Therapeutics to Advance Novel Oral Therapy for Sickle Cell Disease

Zynext Ventures, the venture capital arm of Zydus Lifesciences, has invested in Illexcor Therapeutics to support the development of a novel oral therapy for sickle cell disease.

Global Pharma | 13/03/2025 | By Manvi |  397

BGS US Secures ISO Certifications for New Electron Beam Sterilisation Facility

The facility will begin operations in mid-2025.

Global Pharma | 13/03/2025 | By Abha |  202

Almac Group Unveils EUR 65M Commercial Manufacturing Facility in Northern Ireland

The new 100,000sq ft facility enhances existing capabilities in commercial manufacture of oral dose treatments for a variety of therapeutic areas.

Global Pharma | 13/03/2025 | By Abha |  492

Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin in India

Glenmark Pharmaceuticals has launched Empagliflozin, a widely recognised SGLT2 inhibitor under the brand Glempa, a range of Empagliflozin-based medications in India, offering advanced and affordable treatment options for type 2 diabetes mellitus with cardiovascular benefits.

Global Pharma | 12/03/2025 | By Manvi |  1351

SK bioscience Ships 750,000 Doses of SKYCellflu to Southern Hemisphere Markets

SK bioscience announced that the company has begun shipping its self-developed influenza vaccine, SKYCellflu, from its vaccine manufacturing facility L HOUSE to Southern Hemisphere markets, including Southeast Asia and Latin America.

Global Pharma | 12/03/2025 | By Manvi |  364

Exogenus Picks Lonza to Develop GMP-Compliant Process to Manufacture Exo-101

Exogenus Therapeutics specializes in the development of healthcare solutions based on extracellular vesicles, including exosomes and other nanotechnologies.

Global Pharma | 12/03/2025 | By Aishwarya |  444